J. B. Chemicals & Pharmaceuticals (JBCHEPHARM.BO) Earnings Analysis
J. B. Chemicals & Pharmaceuticals (JBCHEPHARM.BO) next reports earnings on 2026-08-06, consensus EPS 13.55 INR. Last quarter (2026-05-11) it missed with EPS 7.7 INR vs 9.9 INR est (-22.2%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E 53.41.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does JBCHEPHARM.BO next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 13.55 INR |
| Revenue estimate | 11.18B |
JBCHEPHARM.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | 7.7 INR | 9.9 INR | -22.2% | Miss |
| 2026-02-02 | 12.7 INR | 12.3 INR | +3.3% | Beat |
| 2026-01-16 | 12.7 INR | 10.2 INR | +24.5% | Beat |
| 2025-05-15 | 9.17 INR | 8.6 INR | +6.6% | Beat |
| 2024-08-08 | 11.16 INR | 9.8 INR | +13.9% | Beat |
Beat rate: 4/5 (80%) over reported quarters with consensus data.
JBCHEPHARM.BO valuation and analyst view
| Trailing P/E | 53.41 |
|---|---|
| Trailing EPS | 44.442 INR |
| Price / book | 9.27 |
| Dividend yield | 0.91% |
| Market cap | 386.77B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is J. B. Chemicals & Pharmaceuticals (JBCHEPHARM.BO)'s next earnings date?
J. B. Chemicals & Pharmaceuticals is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 13.55 INR and revenue estimate of 11.18B.
Did JBCHEPHARM.BO beat earnings last quarter?
In its 2026-05-11 report, JBCHEPHARM.BO posted EPS of 7.7 INR versus a 9.9 INR estimate — a miss of 22.2%.
What is JBCHEPHARM.BO's earnings track record?
Over the last 5 reported quarters with consensus data, JBCHEPHARM.BO beat estimates 4 times (80%).
What is JBCHEPHARM.BO's current P/E ratio and EPS?
JBCHEPHARM.BO trades at a trailing P/E of 53.41 on trailing EPS of 44.44179957153059 INR.
What do analysts rate JBCHEPHARM.BO?
JBCHEPHARM.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.